Certain fusions are associated with an aggressive clinical course and inferior overall survival, such as CIC-DUX4 fusion [70], which was reported in Ewing’s sarcoma as well as undifferentiated round cell sarcoma in our cohort. This evidence concerns the gene DUX4 and Ewing sarcoma.